Current stage?-Stage III - Page 13 of 33 Posts on Medivizor
Navigation Menu

Current stage?-Stage III Posts on Medivizor

Is abemaciclib combined with fulvestrant effective in women with HR positive advanced breast cancer?

Is abemaciclib combined with fulvestrant effective in women with HR positive advanced breast cancer?

Posted by on Jul 15, 2017 in Breast cancer | 0 comments

In a nutshell This study aimed to compare the effectiveness of the combination of fulvestrant (Faslodex) and abemaciclib to fulvestrant alone in patients with advanced breast cancer. This study concluded that the combination of fulvestrant and abemaciclib had improved outcomes for patients when compared to fulvestrant alone.  Some background...

Read More

Are beta blockers useful in advanced breast cancer?

Are beta blockers useful in advanced breast cancer?

Posted by on Jun 5, 2017 in Breast cancer | 0 comments

In a nutshell This study aimed to investigate the association between beta blocker use and outcomes in HER2 negative breast cancer (BC) patients. This study concluded that beta blocker use leads to improved progression free survival in BC patients.  Some background Beta blockers are therapies used to treat various heart related conditions....

Read More

A comparison of how FEC120 treatment vs EC-docetaxel treatment affect survival in patients with node-positive primary breast cancer

A comparison of how FEC120 treatment vs EC-docetaxel treatment affect survival in patients with node-positive primary breast cancer

Posted by on Apr 13, 2017 in Breast cancer | 0 comments

In a nutshell This study compared the side effects and outcome of two drug regimens in women with high-risk node-positive breast cancer (BC). Both treatment regimens were found to have similar survival outcomes. Some background Standard treatment in node positive BC (cancer that has spread to the lymph nodes) consists of two categories of...

Read More

How effective is metronomic chemotherapy with vinorelbine and capecitabine in patients with advanced HER2-negative breast cancer?

How effective is metronomic chemotherapy with vinorelbine and capecitabine in patients with advanced HER2-negative breast cancer?

Posted by on Apr 3, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated whether metronomic chemotherapy with oral vinorelbine (Navelbine) and capecitabine (Xeloda) was effective in treating patients with advanced HER2-negative breast cancer (BC). This form of treatment was found to be safe and effective for this patients group. Some background Metronomic chemotherapy is a form of...

Read More

The impact of exercise on the risk of cardiovascular events in women with non-metastatic breast cancer

The impact of exercise on the risk of cardiovascular events in women with non-metastatic breast cancer

Posted by on Mar 20, 2017 in Breast cancer | 0 comments

In a nutshell This study investigated whether exercise was associated with a reduction in the risk of cardiovascular disease (CVD) in patients with non-metastatic breast cancer (BC). Exercise was found to be linked to a significant reduction in the risk of CVD for this patient group. Some background CVD is a leading cause of death among women with...

Read More

Chemotherapy after rectal cancer surgery is associated with improved survival

Chemotherapy after rectal cancer surgery is associated with improved survival

Posted by on Mar 13, 2017 in Colorectal cancer | 0 comments

In a nutshell This study investigated whether chemotherapy after rectal surgery improves survival of rectal cancer patients. Researchers suggested that chemotherapy after rectal surgery is associated with improved survival.  Some background Rectal cancer affects almost 40,000 people annually in the United States. Roughly 50% of these patients...

Read More

Can radiation and hormone therapy after surgery improve prostate cancer survival rates?

Can radiation and hormone therapy after surgery improve prostate cancer survival rates?

Posted by on Jan 21, 2017 in Prostate cancer | 1 comment

In a nutshell The aim of this study was to determine whether radiation therapy in combination with hormonal therapy improved survival in men with prostate cancer that has spread to the lymph nodes after surgery. Researchers concluded that patients treated with radiation therapy and hormone therapy had a significantly higher survival rate compared to...

Read More